Valiant Laboratories Limited (NSE:VALIANTLAB)
India · Delayed Price · Currency is INR 60.33
-1.41 (-2.28%)
Jul 30, 2026, 2:52 PM IST
Valiant Laboratories Market Cap
Valiant Laboratories has a market cap or net worth of 3.35 billion as of July 30, 2026. Its market cap has decreased by -14.07% in one year.
Market Cap
3.35B
Enterprise Value
3.48B
Revenue
2.37B
Ranking
n/a
PE Ratio
n/a
Stock Price
60.33
ChartMarket Cap Chart
Since October 6, 2023, Valiant Laboratories's market cap has decreased from 7.40B to 3.35B, a decrease of -54.67%. That is a compound annual growth rate of -24.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.35B | -11.80% |
| Dec 31, 2025 | 3.80B | -21.26% |
| Dec 31, 2024 | 4.83B | -35.84% |
| Dec 29, 2023 | 7.53B | 1.73% |
| Oct 6, 2023 | 7.40B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 17.85B |
| Windlas Biotech | 17.70B |
| Jagsonpal Pharmaceuticals | 15.14B |
| Sigachi Industries | 9.91B |
| Bafna Pharmaceuticals | 5.63B |
| Nectar Lifesciences | 2.02B |
| Brooks Laboratories | 1.89B |
| Alpa Laboratories | 1.40B |